Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?

By  

Current Medicinal Chemistry, Vol. 25, Iss. 31, 2018-09 ,pp. : 3682-3702

Bentham Science Publishers

Access to resources Recommend Favorite

Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2701-2705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of tacrolimus equation to predict troughs using genetic and clinical factors

By Passey Chaitali   Birnbaum Angela K   Brundage Richard C   Schladt David P   Oetting William S   Leduc Robert E   Israni Ajay K   Guan Weihua   Matas Arthur J   Jacobson Pamala A  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1141-1147

Future Medicine

Access to resources Recommend Favorite

Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients

By Wang Ping   Mao Yong   Razo Juan   Zhou Xiaobo   Wong Stephen TC   Patel Samir   Elliott Erin   Shea Erin   Wu Alan HB   Gaber A Osama  

Pharmacogenomics, Vol. 11, Iss. 10, 2010-10 ,pp. : 1389-1402

Future Medicine

Access to resources Recommend Favorite

Although the symptoms of Huntington's disease can be treated, the course of the disease cannot currently be altered

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 10, 2010-10 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite